Young adult LDL ≥100 mg/dL tied to 64% increased risk for CHD, independent of later levels.
The World Health Organization (WHO) has updated the WHO Model List of Essential Medicines for 2019.
Dose-dependent relationship seen in a large national cohort of US veterans.
Residential exposure linked to AH, reduced HDL cholesterol for individuals living in multistory houses.
Fasting, nonfasting levels show similar associations with cardiovascular events even for patients on statins.
Further studies are needed to determine the threshold of risk at which it is safe to withhold therapy for prevention of atherosclerotic cardiovascular disease in elderly people.
Higher percent trunk fat and lower percent leg fat linked to increased risk of cardiovascular disease.
The safety and efficacy of direct oral anticoagulants were associated with significant overall reductions in mortality in venous thromboembolism compared with observation alone.
Persistent low vitamin D from birth to early childhood linked to higher risk of elevated SBP from age 3 to 18.
Regular assessment of adherence to blood pressure-lowering drugs as well as directly observed therapy may be helpful for resolving treatment-resistant hypertension.
Lower risk of all-cause mortality for adults with increasing physical activity trajectories over time.
The incidence of infection increases with glucocorticoid dose for patients with polymyalgia rheumatica or giant cell arteritis.
The increased CVD risk found in women with hypertensive pregnancy disorders was associated with conventional risk factors.
Majority of patients with heart attack <50 years still have high cholesterol one year later.
Increase of at least half a serving a day of red meat, especially processed meat, linked to greater risk.
Globally, suboptimal fruit, vegetable intake causes millions of CHD, stroke deaths per year.
The AHA/ACC published a new clinical practice guideline on managing cholesterol and provided a risk assessment report on primary prevention of ASCVD.
The LIFEtime-perspective CardioVascular Disease model can accurately estimate individual-level prognosis and treatment-effects in terms of improved 10-year risk, lifetime risk, and life-expectancy free of cardiovascular disease.
Prophylactic prevention reduces nonfatal ischemic events but significantly increases nonfatal bleeding events.
Algorithms may help predict cardiovascular disease risk in people living with HIV.